$FOLD Janney Capital Sees 42% Upside In Amicus Therapeutics Following Positive Phase 3 Data http://www.smarteranalyst.com/2014/08/20/janney-capital-sees-42-upside-in-amicus-therapeutics-following-positive-phase-3-data/